Best of the other journals

Harnik, Erika; Lee, Rachel; Rampersad, Anjali

doi:10.1111/cea.13851

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study in the United Kingdom (UK) attempted home allergy testing, sending kits for blood collection via finger prick sampling to the families. This approach was found particularly helpful in those residing far from the hospital and keen to avoid unnecessary travel during the pandemic and provided an opportunity to confirm or exclude allergy 46 . Another study from the UK showed that telehealth team medicine approach in severely asthmatic children with home spirometry resulted in reduced admissions, fewer missed visits, and no increase in steroid or antibiotic prescriptions.…”

Section: Pandemic Impact On Patient Care and Mitigation Strategiesmentioning

confidence: 99%

Allergic diseases and immunodeficiencies in children, lessons learnt from COVID‐19 pandemic by 2022: A statement from the EAACI‐section on pediatrics

Munblit

Greenhawt

Brough

et al. 2022

Pediatric Allergy Immunology

View full text Add to dashboard Cite

By the April 12, 2022, the COVID‐19 pandemic had resulted in over half a billion people being infected worldwide. There have been 6.1 million deaths directly due to the infection, but the pandemic has had many more short‐ and long‐term pervasive effects on the physical and mental health of the population. Allergic diseases are among the most prevalent noncommunicable chronic diseases in the pediatric population, and health‐care professionals and researchers were seeking answers since the beginning of pandemic. Children are at lower risk of developing severe COVID‐19 or dying from infection. Allergic diseases are not associated with a higher COVID‐19 severity and mortality, apart from severe/poorly controlled asthma. The pandemic disrupted routine health care, but many mitigation strategies, including but not limited to telemedicine, were successfully implemented to continue delivery of high‐standard care. Although children faced a multitude of pandemic‐related issues, allergic conditions were effectively treated remotely while reduction in air pollution and lack of contact with outdoor allergens resulted in improvement, particularly respiratory allergies. There is no evidence to recommend substantial changes to usual management modalities of allergic conditions in children, including allergen immunotherapy and use of biologicals. Allergic children are not at greater risk of multisystem inflammatory syndrome development, but some associations with Long COVID were reported, although the data are limited, and further research is needed. This statement of the EAACI Section on Pediatrics provides recommendations based on the lessons learnt from the pandemic, as available evidence.

show abstract

Section: Pandemic Impact On Patient Care and Mitigation Strategiesmentioning

confidence: 99%